Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Aurinia Pharmaceuticals Inc
PP&E Net
Aurinia Pharmaceuticals Inc
PP&E Net Peer Comparison
Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
PP&E Net
$112m
|
CAGR 3-Years
120%
|
CAGR 5-Years
209%
|
CAGR 10-Years
N/A
|
|
Zymeworks Inc
NYSE:ZYME
|
PP&E Net
$37.5m
|
CAGR 3-Years
29%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
Theratechnologies Inc
TSX:TH
|
PP&E Net
$1.8m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
18%
|
CAGR 10-Years
25%
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
PP&E Net
$7.5m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
PP&E Net
$23.9m
|
CAGR 3-Years
129%
|
CAGR 5-Years
85%
|
CAGR 10-Years
N/A
|
|
Spectral Medical Inc
TSX:EDT
|
PP&E Net
CA$850k
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
4%
|
See Also
What is Aurinia Pharmaceuticals Inc's PP&E Net?
PP&E Net
112m
USD
Based on the financial report for Mar 31, 2024, Aurinia Pharmaceuticals Inc's PP&E Net amounts to 112m USD.
What is Aurinia Pharmaceuticals Inc's PP&E Net growth rate?
PP&E Net CAGR 5Y
209%
Over the last year, the PP&E Net growth was 1 187%. The average annual PP&E Net growth rates for Aurinia Pharmaceuticals Inc have been 120% over the past three years , 209% over the past five years .